Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million ...Middle East

PR Newswire - News
Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million )

    Also on site :